アブストラクト | Objective: To describe the clinical characteristics of hypoglycemia that develop with tigecycline therapy and to review and summarize the current evidence of this uncommonly occurring metabolic adverse effect of tigecycline therapy. Underlying risk factors and potential mechanisms are also discussed. Data source: A 3-phase literature search was performed. In phase 1, the Cochrane Central Register of Controlled Trials (CENTRAL) Library, MEDLINE, and Embase electronic databases were searched for hypoglycemia and tigecycline, published from inception until August 2023. In phase 2, MEDLINE was searched for tigecycline randomized controlled trials and results were manually screened for hypoglycemia. In phase 3, the US Food and Drug Administration Adverse Event Reporting System public dashboard was searched for reports on tigecycline and hypoglycemia from June 2005 until July 2023. Study selection and data extraction: Relevant English-language citations and those conducted in humans were considered. Relevance to patient care and clinical practice: Hypoglycemia of various causes is an independent mortality risk. This review raises awareness among clinicians about the possibility of hypoglycemia with tigecycline therapy. Conclusion: Data on tigecycline-related hypoglycemia are scarce. Hypoglycemia may occur at any time during tigecycline therapy and can be severe and persist for days after tigecycline cessation. Renal dysfunction or renal replacement therapy may predispose to severe hypoglycemia during tigecycline therapy. Tigecycline-related hypoglycemia may develop in patients with or without diabetes mellitus and appears independent of insulin or antidiabetic agents. Intravenous dextrose showed efficacy in the restoration of euglycemia. Studies are needed to determine whether tigecycline-related hypoglycemia is iatrogenic or spontaneous. |
ジャーナル名 | The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians |
Pubmed追加日 | 2024/2/6 |
投稿者 | Hakeam, Hakeam A; Sarkhi, Khadija A; Iansavichene, Alla |
組織名 | Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre,;Riyadh, Saudi Arabia.;College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.;Pharmaceutical Care Services, King Fahad Armed Forces Hospital, Jeddah, Saudi;Arabia.;Health Sciences Library, London Health Sciences Centre, London, ON, Canada. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38318259/ |